Hims

HIMS Stock Slides Overnight: CEO Sees Healthcare Potential In Anthropic's AI Leap As Lilly, WeightWatchers Turn Up The Heat

June 6, 2026

CEO Andrew Dudum called Anthropic’s latest AI breakthrough “transformative” for population health, saying AI is moving “from super…

MMedication

Hims & Hers abandons plan for cheaper Wegovy knockoff after FDA warning

March 11, 2026

Telehealth company Hims & Hers dropped its plan to offer a knockoff version of the weight-loss pill Wegovy…

MMedication

Hims & Hers will sell real Ozempic in deal with Novo Nordisk

March 11, 2026

Hims & Hers and the Danish pharma giant Novo Nordisk have ended a bitter legal feud that will…

MMedication

March 10, 2026

After two splashy Super Bowl commercials focused on making weight loss medication more accessible, Hims & Hers will…

MMedication

Taking the new Wegovy pill every day is really complicated. Will patients stick with it?

February 11, 2026

Published: Feb. 10, 2026 at 3:48 p.m. ET Patients are thrilled that there’s finally a GLP-1 pill, but swallowing…

HHealthcare

February 7, 2026

Super Bowl Sunday is the holy grail of advertising thanks to its massive viewership, with an average of…

MMedication

What Consumers Should Know About the Reported $49 Compounded Semaglutide Pill, Novo Nordisk Response, and Telehealth Prescription Access in 2026

February 6, 2026

Hims An informational overview of reported February 2026 developments, FDA-approved vs. compounded medication distinctions, Wegovy pill category context,…

MMedication

Hims and Hers Health's compounded Wegovy pill offering fuels market jitters

February 5, 2026

Feb 5 (Reuters) – Hims & Hers said it would begin offering compounded versions of Novo Nordisk’s Wegovy…

MMedication

Hims launches $49 compounded copy of Wegovy weight-loss pill

February 5, 2026

By Amina Niasse NEW YORK, Feb 5 (Reuters) – Online telehealth company Hims and Hers Health will start…

HIMS Stock Slides Overnight: CEO Sees Healthcare Potential In Anthropic’s AI Leap As Lilly, WeightWatchers Turn Up The Heat

Hims & Hers abandons plan for cheaper Wegovy knockoff after FDA warning

Hims & Hers will sell real Ozempic in deal with Novo Nordisk

The era of $199 copycat weight loss drugs is ending — and it could cost patients

Taking the new Wegovy pill every day is really complicated. Will patients stick with it?

The most controversial Super Bowl ad of 2025 is back for more

What Consumers Should Know About the Reported $49 Compounded Semaglutide Pill, Novo Nordisk Response, and Telehealth Prescription Access in 2026

Hims and Hers Health’s compounded Wegovy pill offering fuels market jitters

Hims launches $49 compounded copy of Wegovy weight-loss pill